Program Leader: Li Mao, M.D.
The Experimental Therapeutics Program (ET) consists of members from the School of Medicine (representing several departments) and the School of Pharmacy. Program members are supported by many individual peer-reviewed grants. The unifying theme of this Program is to build translational clinical trials based on innovative and novel laboratory research projects.
The Program's scientific goals are:
To accomplish these goals, the ET Program is composed of interacting groups of investigators working in the following thematic areas:
ET program activities are greatly enhanced by extensive interactions with other cancer center programs. Program members are frequent users of Cancer Center Shared Services. The Cancer Center also supports monthly Program meetings and yearly Program scientific retreats. The increasing numbers of cancer-directed translational and clinical studies developed by program members is a manifestation of the success of this program.